11 results in Exploration of Musculoskeletal Diseases
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Review
How URAT1 inhibitors can shape the future of chronic gout treatment: a narrative review of uricosurics past and present
Robert T. Keenan ... Michael H. Pillinger
Published: December 12, 2024 Explor Musculoskeletal Dis. 2024;2:529–554
This article belongs to the special issue Pharmacological and Non-Pharmacological Management of Gout
Open Access
Commentary
Should all people starting urate-lowering therapy for gout receive anti-inflammatory prophylaxis?
Edward Roddy ... Christian D. Mallen
Published: November 15, 2024 Explor Musculoskeletal Dis. 2024;2:521–528
This article belongs to the special issue Pharmacological and Non-Pharmacological Management of Gout
Open Access
Original Article
Evaluation of continued 2-monthly or annual urate monitoring in gout: an extension of the GoutSMART randomised controlled feasibility trial
Philip L. Riches ... Amrey Krause
Published: November 11, 2024 Explor Musculoskeletal Dis. 2024;2:509–520
This article belongs to the special issue Pharmacological and Non-Pharmacological Management of Gout
Open Access
Commentary
Addressing weight loss management in obese gout patients: guidance for future trials
Robin Christensen ... Lisa K. Stamp
Published: November 07, 2024 Explor Musculoskeletal Dis. 2024;2:498–508
This article belongs to the special issue Pharmacological and Non-Pharmacological Management of Gout
Open Access
Mini Review
Can Janus kinase inhibitors be used to treat immune checkpoint inhibitor associated adverse events?
Jürgen Braun, Kirsten Karberg
Published: November 04, 2024 Explor Musculoskeletal Dis. 2024;2:490–497
Open Access
Review
The impact of social media and online communities of practice in rheumatology
Judy L. Seraphine, Alvin F. Wells
Published: October 30, 2024 Explor Musculoskeletal Dis. 2024;2:478–489
This article belongs to the special issue Digital health technologies in rheumatology: emerging evidence and innovation
Open Access
Commentary
Bridging the evidence-practice gap for people with gout
Mark D. Russell, James B. Galloway
Published: October 23, 2024 Explor Musculoskeletal Dis. 2024;2:473–477
This article belongs to the special issue Pharmacological and Non-Pharmacological Management of Gout
Open Access
Review
Uricases: reflections on recent developments in the management of challenging gout patients
Naomi Schlesinger, Dan Kaufmann
Published: October 02, 2024 Explor Musculoskeletal Dis. 2024;2:461–472
This article belongs to the special issue Pharmacological and Non-Pharmacological Management of Gout
Open Access
Review
CPPD—differential diagnostics and differential therapeutic challenges
Maria L. Voulgari, Herbert Kellner
Published: September 25, 2024 Explor Musculoskeletal Dis. 2024;2:443–460
This article belongs to the special issue Calcium Pyrophosphate Deposition Disease
Open Access
Original Article
Factors associated with interstitial lung disease in patients with rheumatoid arthritis
Benyapa Suppa-Udom ... Wanruchada Katchamart
Published: September 14, 2024 Explor Musculoskeletal Dis. 2024;2:431–442
Open Access
Perspective
Selecting the best-value biosimilar in emerging countries
Gilberto Castañeda-Hernández
Published: September 14, 2024 Explor Musculoskeletal Dis. 2024;2:423–430
This article belongs to the special issue Biosimilars: State of the Art in the Treatment of Rheumatic Diseases
PreviousJournal Information